AAAAAA
Results:
1-22
|
Results: 22
Authors:
Emerich, DF
Salzberg, HC
Citation: Df. Emerich et Hc. Salzberg, Tribute to Dr. Thomas J. Walsh, CELL TRANSP, 10(1), 2001, pp. 1-2
Authors:
Emerich, DF
Winn, SR
Citation: Df. Emerich et Sr. Winn, Immunoisolation cell therapy for CNS diseases, CR R THER, 18(3), 2001, pp. 265-298
Authors:
Emerich, DF
Dean, RL
Osborn, C
Bartus, RT
Citation: Df. Emerich et al., The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood-brain barrier - From concept to clinical evaluation, CLIN PHARMA, 40(2), 2001, pp. 105-123
Authors:
Emerich, DF
Snodgrass, P
Dean, RL
Lafreniere, D
Agostino, M
Wiens, T
Xiong, H
Hasler, B
Marsh, J
Pink, M
Kim, BS
Bartus, RT
Citation: Df. Emerich et al., Bradykinin modulation of tumor vasculature: I. Activation of B-2 receptorsincreases delivery of chemotherapeutic agents into solid peripheral tumors, enhancing their efficacy, J PHARM EXP, 296(2), 2001, pp. 623-631
Authors:
Emerich, DF
Dean, RL
Snodgrass, P
Lafreniere, D
Agostino, M
Wiens, T
Xiong, H
Hasler, B
Marsh, J
Pink, M
Kim, BS
Perdomo, B
Bartus, RT
Citation: Df. Emerich et al., Bradykinin modulation of tumor vasculature: II. Activation of nitric oxideand phospholipase A(2)/prostaglandin signaling pathways synergistically modifies vascular physiology and morphology to enhance delivery of chemotherapeutic agents to tumors, J PHARM EXP, 296(2), 2001, pp. 632-641
Authors:
Emerich, DF
Citation: Df. Emerich, Recent efforts to overcome the blood-brain barrier for drug delivery, EXPERT OP T, 10(3), 2000, pp. 279-287
Authors:
Emerich, DF
Winn, SR
Citation: Df. Emerich et Sr. Winn, Application of polymer-encapsulated cell therapy for CNS diseases, NEUROMETH, 36, 2000, pp. 233-277
Authors:
Emerich, DF
Winn, SR
Hu, YH
Marsh, J
Snodgrass, P
LaFreniere, D
Wiens, T
Hasler, BP
Bartus, RT
Citation: Df. Emerich et al., Injectable chemotherapeutic microspheres and glioma I: Enhanced survival following implantation into the cavity wall of debulked tumors, PHARM RES, 17(7), 2000, pp. 767-775
Authors:
Emerich, DF
Winn, SR
Snodgrass, P
LaFreniere, D
Agostino, M
Wiens, T
Xiong, H
Bartus, RT
Citation: Df. Emerich et al., Injectable chemotherapeutic microspheres and glioma II: Enhanced survival following implantation into deep inoperable tumors, PHARM RES, 17(7), 2000, pp. 776-781
Authors:
Emerich, DF
Dean, RL
Marsh, J
Pink, M
Lafreniere, D
Snodgrass, P
Bartus, RT
Citation: Df. Emerich et al., Intravenous Cereport (RMP-7) enhances delivery of hydrophilic chemotherapeutics and increases survival in bats with metastatic tumors in the brain, PHARM RES, 17(10), 2000, pp. 1212-1219
Authors:
Emerich, DF
Citation: Df. Emerich, Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?, TRENDS NEUR, 23(6), 2000, pp. 245-246
Authors:
Bartus, RT
Snodgrass, P
Marsh, J
Agostino, M
Perkins, A
Emerich, DF
Citation: Rt. Bartus et al., Intravenous cereport (RMP-7) modifies topographic uptake profile of carboplatin within rat glioma and brain surrounding tumor, elevates platinum levels, and enhances survival, J PHARM EXP, 293(3), 2000, pp. 903-911
Authors:
Bartus, RT
Snodgrass, P
Dean, RL
Kordower, JH
Emerich, DF
Citation: Rt. Bartus et al., Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: Implications for treating newly emerging tumor colonies, EXP NEUROL, 161(1), 2000, pp. 234-244
Authors:
Emerich, DF
Razee, E
Citation: Df. Emerich et E. Razee, Polymer-encapsulated cells for gene therapy, GENE THERAPY, 2000, pp. 181-207
Authors:
Emerich, DF
Citation: Df. Emerich, Intrastriatal injections of quinolinic acid as a model for developing neuroprotective strategies in Huntington's disease, CONT NEUROS, 2000, pp. 275-299
Authors:
Emerich, DF
Citation: Df. Emerich, Encapsulated CNTF-producing cells for Huntington's disease, CELL TRANSP, 8(6), 1999, pp. 581-582
Authors:
Emerich, DF
Tracy, MA
Ward, KL
Figueiredo, M
Qian, RL
Henschel, C
Bartus, RT
Citation: Df. Emerich et al., Biocompatibility of poly (DL-lactide-co-glycolide) microspheres implanted into the brain, CELL TRANSP, 8(1), 1999, pp. 47-58
Authors:
Lindner, MD
Cain, CK
Plone, MA
Frydel, BR
Blaney, TJ
Emerich, DF
Hoane, MR
Citation: Md. Lindner et al., Incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine produce akinesia, rigidity, tremor and cognitive deficitsin middle-aged rats, BEH BRA RES, 102(1-2), 1999, pp. 1-16
Authors:
Bartus, RT
Emerich, DF
Citation: Rt. Bartus et Df. Emerich, Cholinergic markers in Alzheimer disease, J AM MED A, 282(23), 1999, pp. 2208-2208
Authors:
Kordower, JH
Isacson, O
Emerich, DF
Citation: Jh. Kordower et al., Cellular delivery of trophic factors for the treatment of Huntington's disease: Is neuroprotection possible?, EXP NEUROL, 159(1), 1999, pp. 4-20
Authors:
Emerich, DF
Snodgrass, P
Dean, R
Agostino, M
Hasler, B
Pink, M
Xiong, H
Kim, BS
Bartus, RT
Citation: Df. Emerich et al., Enhanced delivery of carboplatin into brain tumours with intravenous Cereport (TM) (RMP-7): dramatic differences and insight gained from dosing parameters, BR J CANC, 80(7), 1999, pp. 964-970
Authors:
Emerich, DF
Bartus, RT
Citation: Df. Emerich et Rt. Bartus, Intracellular events associated with cerebral ischemia, STROKE THERAPY, 1999, pp. 195-218
Risultati:
1-22
|